-- Evofem's Cost to Manufacture PHEXXI will Decrease by 55% - 60% -- SAN DIEGO, March 26, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the Company) today announced that it has entered into a License and Supply Agreement (L&S Agreement) with Windtree Therapeutics,...
Hence then, the article about evofem expects significant reduction in phexxi manufacturing cost through agreement with windtree therapeutics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics )
Also on site :
- Salt Typhoon is hacking the world’s phone and internet giants. Here’s everywhere that’s been hit.
- Family of tragic Staffordshire youngster killed in crash on Lichfield A-road pay tribute to their 'beautiful young boy'
- Carney confirms: When Washington whistles, Ottawa salutes